Johannes Jacob Pieter Kastelein, Chief Scientific Officer: NewAmsterdam Pharma NAMS Sell · Filed 10/02

Trade details

Type: Insider sale
Amount: $1,257,657.38
Shares · price: 50,246 sh · $25.03 a share
Held after: 69,302 sh
Stock: NewAmsterdam Pharma NAMS
Person: Johannes Jacob Pieter KasteleinChief Scientific Officer
Trade date: 26/09/30
Filed: 26/10/02
Days to filing: 2 days

Sold 42.0% of holdings

Share of holding sold: 42.0%

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 08/31~10/30

Johannes Jacob Pieter Kastelein's recent trades

Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.5M
125,000 sh
$3.5M
Filed 08/24
Traded 08/24
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.2M
104,467 sh
$3.2M
Filed 03/09
Traded 03/05
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.1M
101,409 sh
$3.1M
Filed 03/09
Traded 03/09
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$2.9M
94,124 sh
$2.9M
Filed 03/09
Traded 03/06
Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$9.4M
300,000 sh
$9.4M
Filed 03/05
Traded 03/02